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DNA double strand breaks (DSBs) are the most cytotoxic lesions of those occurring in
the DNA and can lead to cell death or result in genome mutagenesis and chromosomal
translocations. Although most of these rearrangements have detrimental effects for
cellular survival, single events can provide clonal advantage and result in abnormal
cellular proliferation and cancer. The origin and the environment of the DNA break or
the repair pathway are key factors that influence the frequency at which these events
appear. However, the molecular mechanisms that underlie the formation of chromosomal
translocations remain unclear. DNA topoisomerases are essential enzymes present in
all cellular organisms with critical roles in DNA metabolism and that have been linked
to the formation of deleterious DSBs for a long time. DSBs induced by the abortive
activity of DNA topoisomerase II (TOP2) are “trending topic” because of their possible
role in genome instability and oncogenesis. Furthermore, transcription associated TOP2
activity appears to be one of the most determining causes behind the formation of
chromosomal translocations. In this review, the origin of recombinogenic TOP2 breaks
and the determinants behind their tendency to translocate will be summarized.
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INTRODUCTION
Chromosomal translocations are rearrangements of large fragments of DNA. When transcribed
regions are affected, genome translocations usually result in the inactivation of one or a
group of genes with the consequent deleterious effects for cellular survival. However, on
occasion, translocations can generate chimeric proteins or deregulate transcription programmes
creating abnormal growth capacities and contributing to malignancy and tumor development.
Over 10,000 gene fusions have been found in cancer, most of which are considered
passenger mutations, consequence of the intrinsic instability of tumor progression. Among
them, more than 300 are recurrent and contribute to initial stages of cellular disarray
(Mitelman et al., 2007; Mertens et al., 2015).
Recurrence of chromosomal translocations is determined by a large number of factors, starting
from the nature of the DNA break and including the pathway involved in its repair, the cell cycle
stage, the chromatin status of the locus, and the genomic location of the lesion. Since most of these
factors are dynamic and interconnected, their relative relevance is difficult to establish, and many
aspects of the origin of genomic translocations remain unclear. Recent studies have unveiled that
transcription and 3D organization of the genome are two major determinants in the appearance
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of DNA double-stranded breaks (DSBs) and they promote
chromosomal translocations. In this brief review how DNA
topoisomerase II (TOP2) appears at the crossroad of these factors
will be discussed.
DNA TRANSACTIONS AND TOP2 ACTIVITY
DNA topoisomerases are essential enzymes present in all
cellular organisms with critical roles in DNA metabolism. DNA
topoisomerases release the torsional stress generated in the DNA
by a wide variety of processes including replication, transcription,
3D genome organization, and chromosome segregation
(Pommier et al., 2016). According to their mechanism of action,
DNA topoisomerases are classified in two types depending on
whether they cut one (type I) or two strands (type II) of the
DNA double helix. TOP2 is a type II enzyme that can pass
an intact DNA duplex through a broken one while covalently
bound to the DNA. Once strand passage is completed, the
enzyme reseals the break (Nitiss, 2009a). Vertebrates express two
TOP2 isoforms, TOP2α and TOP2ß. While TOP2ß is expressed
throughout the cell cycle, TOP2α levels correlate with cellular
proliferation and peak at S and G2/M phases. TOP2α has a major
role in replication and chromosome segregation. TOP2ß activity
has been mainly associated to transcription. It participates in:
transcription elongation, conserving the structure of either active
or inactive promoters, promoting the activation of hormone-
driven, and early response genes and in the release of paused
RNA polymerases (Ju, 2006; Haffner et al., 2010; Madabhushi
et al., 2015; Dellino et al., 2019).
A key intermediate of topoisomerase activity is the cleavage
complex (TOP2cc), formed when the topoisomerase cleaves the
DNA and each subunit of the TOP2 dimer becomes covalently
linked to the 5′-terminus of the break via a phosphotyrosyl bond
(Vos et al., 2011) (Figure 1). Although the cleavage complex
is normally transient, naturally due to unclear circumstances
or induced by the presence of anti-tumor agents that act as
topoisomerase “poisons” the cleaved intermediate can result in
the formation of abortive (irreversible) TOP2cc, a singular DSB
(Deweese and Osheroff, 2009; Nitiss, 2009b).
TOP2 AND ONCOGENIC
TRANSLOCATIONS
TOP2-associated translocations are main drivers of some
common hematological and solid tumors (Felix et al., 2006;
Haffner et al., 2010). Oncogenic translocations related to TOP2
have been mainly associated to TOP2ß activity (Nitiss, 2009a;
Pommier et al., 2016; Madabhushi, 2018). However, after many
years of study, we only start to understand the molecular
mechanisms that direct TOP2-induced rearrangements.
In prostate cancer, androgen-regulated genes are frequently
fused to transcription factors of the ETS family. For instance, the
fusion of TMPRSS2 and ERG occurs inmore than 50% of prostate
malignancies resulting in a hormone-dependent expression of
ERG in prostate tissue (Kumar-Sinha et al., 2008). TMPRSS2 and
ERG expression has been linked to TOP2 activity since TOP2ß
FIGURE 1 | TOP2-induced chromosomal translocations. Model representing
the repair of TOP2 abortive breaks and the influence of TDP2-dependent and
independent NHEJ on TOP2-induced translocations.
participates in the androgen-dependent activation of these
genes. Androgen signaling promotes co-recruitment of androgen
receptor and TOP2ß to TMPRSS2 and ERG breakpoints, which
can trigger recombinogenic DSBs (Haffner et al., 2010).
Recurrent fusions involving MLL and members of the super-
elongation complex, such as AF4 and AF9, account for 10–
30% of secondary and infant acute myeloid leukemia (AML)
(Mitelman et al., 2007; Mertens et al., 2015). Numerous
potential mechanisms for MLL breakage have been proposed,
from Alu-mediated recombination to TOP2ß-induced breaks
(Cowell and Austin, 2012; Wright and Vaughan, 2014). Notably,
secondary leukemias are those resulting from the use of genotoxic
chemotherapeutical drugs, mainly alkylating agents or TOP2
inhibitors, uplifting the direct connection between TOP2 and
translocations in MLL (Wright and Vaughan, 2014). The link of
infant leukemia with TOP2 abortive activity is less clear but a
correlation with dietary flavonoids, natural TOP2 poisons, has
been proposed (Ross, 2000).
THE CONTRIBUTION OF TOP2 IN THE
CELLULAR POOL OF DSBs
The first factor influencing the propensity of a region to
translocate is the frequency of DNA breakage. DSBs can arise
directly from exogenous threats (clastogens), such as radiation
and chemotherapeutic or industrial chemicals. Endogenous
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threats are stochastic activity of apoptotic caspases, nucleases
such as RAG1 and RAG2, and TOP2 (Ashour et al., 2015;
Lieber, 2016). DSBs can also form indirectly from coincident
single strand breaks (SSBs), induced exogenously by alkylating
chemotherapeutical agents, or naturally by type I DNA
topoisomerases, reactive oxygen species (ROS), or activation-
induced cytidine deaminase (AID) (Xu et al., 2012; Rulten and
Caldecott, 2013). DNA replication across SSBs also generates
single ended DSBs (Kuzminov, 2001). This is a prominent source
of DSBs, since SSBs are known to be as frequent as 50,000
per day per cell (Lindahl, 1993). Finally, replication stress, due
to replication fork encountering with inter-strand crosslinks or
non-B forms of DNA such as RNA-DNA hybrids (R-loops), is
also known to promote DSB formation (Gómez-González and
Aguilera, 2019).
The most precise information about endogenous DSBs comes
from non-biased DSB mapping methods, developed to evaluate
illegitimate cleavage by RAG nucleases, and AID in B cells or
by CRISPR-Cas (Chiarle et al., 2011; Crosetto et al., 2013; Tsai
et al., 2014; Frock et al., 2015; Canela et al., 2016; Lensing et al.,
2016; Yan et al., 2017). These studies draw twomajor conclusions.
The first one is that recurrent translocations (typically those that
drive specific cancers) are mostly tissue-specific and triggered
by recurrent DSBs. For instance, RAG off-target sites have been
efficiently detected in activated mouse B-cells in which Rag1 and
Rag2 are induced, supporting the role of stochastic activity of
these nucleases in the formation of B-cell specific DSBs (Kuo and
Schlissel, 2009; Chiarle et al., 2011; Canela et al., 2016).
The second conclusion of these studies, and probably the
most ground-breaking, is that there are more stochastic sources
of DSBs that are not cell-cycle nor tissue-specific but can be
consistently detected in mice and human cells. Some of these
are related to replication stress and frequently appear in long
gene bodies, which are prone to undergo late replication and
are predisposed to replication-transcription conflicts (Canela
et al., 2016; Wei et al., 2016). Notably, others, a bulky group of
them (over 60%), increase in frequency in the presence of the
TOP2 poison etoposide (Canela et al., 2017). These breakpoints,
concentrate in chromatin loop boundaries, gene bodies and
promoter-proximal locations, frequently transcription start sites
(TSS) (Chiarle et al., 2011; Schwer et al., 2016; Yan et al., 2017).
But, what is the origin of these DSBs? TOP2ß is positioned
at loop anchors, this is, CTCF/cohesin (RAD21) binding sites
that flank topologically associating domains, suggesting that it
might be required to solve topological problems during loop
extrusion dynamics (Uusküla-Reimand et al., 2016). Etoposide-
induced TOP2cc can be detected in these loci, independently
of transcription and replication activities (Canela et al., 2017).
But these are reversible TOP2cc. Contrary, detection of abortive
TOP2cc (irreversible) by DSB or protein-linked mapping has
demonstrated that the induction of DSBs at loop anchors by
TOP2 activity is largely depend on active transcription (Canela
et al., 2019; Gittens et al., 2019; Gothe et al., 2019). In fact, a
large number of TOP2ß-associated breaks also concentrate in
gene bodies and around TSS, independently of RAD21 (Chiarle
et al., 2011; Schwer et al., 2016; Canela et al., 2017; Yan et al.,
2017; Gittens et al., 2019; Gothe et al., 2019). Importantly,
distribution of TOP2 breaks around TSS positively correlates
with transcription levels at these loci (Gittens et al., 2019).
Indeed, the inhibition of transcription elongation prevents TOP2
breakage at these loci suggesting that transcription is a major
driving force in TOP2 abortive cycles (Gómez-Herreros et al.,
2017; Gothe et al., 2019). For instance, breaks at TSS associate
with promoter fragility suggesting that events such as RNA
polymerase II pause release requires TOP2 activity and is a source
of DSBs (Dellino et al., 2019).
Regarding TOP2 isoforms, both TOP2α and TOP2ß influence
DNA breakage at these hotspots (Yu et al., 2017; Gothe et al.,
2019). Intriguingly, and despite a similar localization of both
isoforms, TOP2ß-lacking cells reduce breakage at these loci,
suggesting a dominant role of TOP2ß over TOP2α (Cowell et al.,
2012; Canela et al., 2017).
In theory, any DSB can be a potential origin of a
rearrangement. Interestingly, oncogenic breakpoints such as
those found in TMPRSS2, ERG, MLL, AF4, and AF9, among
many others, are localized to TOP2ß/CTCF/RAD21 breakpoints
(Canela et al., 2017, 2019; Gothe et al., 2019). Moreover,
TOP2-induced breaks have been detected by high-throughput,
genome-wide translocation sequencing (HTGTS). HTGTS “fish”
breaks genome wide using a bait DSB in a controlled locus
(Chiarle et al., 2011; Frock et al., 2015). HTGTS has revealed
the tendency of TOP2-induced breaks to translocate, with
highly transcribed genes translocating more than with non-
transcribed ones (Chiarle et al., 2011; Wei et al., 2016; Canela
et al., 2019). Some of these hotspots are localized in TSS
(Schwer et al., 2016).
ILLEGITIMATE TOP2 DSB REPAIR
The illegitimate repair of DNA ends in trans is mediated by
DNA repair pathways, but how often and why are breaks
incorrectly joined is not clear. The two major pathways involved
in the repair of DSBs in eukaryotic cells are non-homologous
end joining (NHEJ) and homologous recombination (HR). HR
occurs specifically in late S and G2 phases of the cell cycle, as it
requires the presence of a sister chromatid for the repair process
(Mehta and Haber, 2014; Wright et al., 2018). HR is considered
an error-free pathway due to the fact that a very large homology,
up to megabases, is used, ensuring the accuracy of the repair
(Symington, 2016). The occurrence of recombination between
homologous chromosomes or tandem repeats has been shown to
be substantially low and HR-deficient cells exhibit higher rates
of genome rearrangements, historically absolving HR for almost
any responsibility in chromosomal translocations (Moynahan
and Jasin, 1997, 2010; Lambert et al., 1999; Stark and Jasin, 2003).
Exceptions to the HR paradigm are Rad51-independent but
homology-directed pathways, Break-Induced Replication (BIR)
and single strand annealing (SSA), which can promote exchanges
in trans (Elliott et al., 2005;Malkova and Ira, 2013; Bhargava et al.,
2016; Sakofsky and Malkova, 2017; Kramara et al., 2018).
In contrast to HR, NHEJ is active throughout the cell
cycle and involves the efficient ligation of DNA ends with
minimal processing at the site of joining. NHEJ is considered
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an error-prone pathway since cellular nucleases trim DNA ends
to make them compatible before ligation (Lieber, 2010). The
homology required in this route is reduced to 1–2 nucleotides,
in case there is any, making NHEJ the ideal scapegoat to provoke
illegitimate joinings (Chang et al., 2017). However, in the absence
of KU70/80 or XRCC4-LIG4, core factors of canonical NHEJ
(cNHEJ), a genetically-different, alternative NHEJ (altNHEJ)
pathway takes over (Yan et al., 2007). altNHEJ is characterized
by a longer homology requirement at the site of break that goes
up to 10–20 bp (McVey and Lee, 2008). Resection is mediated
by CtIP and the MRN complex, similarly to initial stages of HR
(Zhang and Jasin, 2010; Ghezraoui et al., 2014). Base pairing in
trans of these ends results in translocations characterized by short
microhomologies (Guirouilh-Barbat et al., 2004; Kent et al., 2015;
Mateos-Gomez et al., 2015; Sfeir and Symington, 2015; Zahn
et al., 2015).
In the case of TOP2-induced DSBs, trapped TOP2 represents
a particular barrier for ligation, and DNA ends need to be
processed. Abortive TOP2cc are denatured and degraded by the
proteasome, leaving a TOP2-derived peptide of unknown length
covalently bound to the 5
′
phosphate of the DNA through a
tyrosine residue (Zhang et al., 2006; Lin et al., 2008) (Figure 1).
This protein adduct is a hallmark of TOP2 breaks and, like
other blocking lesions, can conditionDSB repair (Álvarez-Quilón
et al., 2014). Resection can generate proficient substrates for HR
independently of the nature of the DNA end and potentially
remove these adducts. In accordance, HR-deficient cells are
hypersensitive to TOP2 poisons, suggesting that TOP2 breaks can
be repaired by HR when available (Gómez-Herreros et al., 2013).
However, remaining topoisomerase can be precisely removed by
Tyrosyl DNA phosphodiesterase 2 (TDP2), which cleaves the
phosphotyrosyl bond between the tyrosine and the 5
′
phosphate
of the DNA (Cortés-Ledesma et al., 2009; Zeng et al., 2010). TDP2
can also remove non-degraded TOP2 in a proteasome-parallel
route stimulated by the SUMO-ligase ZATT (Schellenberg et al.,
2017). Once TOP2 is removed by TDP2, remaining four base-
pair cohesive overhang is ready to be ligated by cNHEJ (Gómez-
Herreros et al., 2013) (Figure 1).
TDP2-mediated pathways protect cells from TOP2 abortive
activity, accelerating TOP2 DSB repair and preventing cell death
and genome instability induced by TOP2 poisons (Gómez-
Herreros et al., 2014, 2017; Zagnoli-Vieira et al., 2018). In
accordance, breaks in MLL induced by the abortive activity
of TOP2 during transcription accumulate in cells lacking
TDP2 (Gómez-Herreros et al., 2017). Notably, TDP2 facilitates
a faithful repair of TOP2 breaks suppressing chromosomal
translocations generated by TOP2 during transcription (Gómez-
Herreros et al., 2017) (Figure 1). Intriguingly, TDP2-processed
ends can also originate chromosomal translocations. A four
base pair homology at break joining can be generated in
cells treated with etoposide and is dependent on TDP2
(Gómez-Herreros et al., 2017) (Figure 1). About 20% of
secondary AML is characterized by this type of junction that
is referred to as “perfect” (Whitmarsh et al., 2003; Meyer
et al., 2005, 2017). A very high number of DSBs might
challenge physiological repair capacities and promote this
illegitimate pairing.
Since TDP2 prevents genome instability and chromosomal
translocations, it has been hypothesized that marginal routes
would promote them (Caldecott, 2012; Gómez-Herreros et al.,
2013, 2017). If HR is not available, in contrast to the “clean” end
processing mediated by TDP2, endonucleases would potentially
generate the loss of information at DNA ends (Figure 1).
However, it has been shown that MRE11, the nuclease activity of
the MRN complex, can process abortive TOP2 DSBs regulated by
a HR-independent role of BRCA1 (Hoa et al., 2016; Sasanuma
et al., 2018). Notably, MRE11 H129N (nuclease deficient)
mutants exhibit increased instability and translocations when
treated with TOP2 poisons (Sasanuma et al., 2018; Gothe et al.,
2019). The contribution of MRE11 and other nucleases such
as ARTEMIS in the repair of physiological levels of TOP2
breaks, their relevance in TOP2 poison-based chemotherapy
and their implication in TOP2-induced genome instability is
under discussion.
Contrary to mouse cells, in which translocations depend
mostly on altNHEJ, cNHEJ mediates translocations induced by
nucleases and ionizing irradiation in humans (Ghezraoui et al.,
2014; Biehs et al., 2017; So and Martin, 2019). However, it has
also been shown that the DSB structure can predispose repair
toward cNHEJ and altNHEJ suggesting that the nature of the
DNA end can condition its repair (So and Martin, 2019). The
role of NHEJ in the formation of TOP2-induced translocations is
controversial. An epistatic effect of Ku70 over TDP2 in etoposide
sensitivity in avian cells suggests that cNHEJ mediates TOP2-
induced DSB repair (Gómez-Herreros et al., 2013). However
LIG4 deficiency increases MLL translocations suggesting that
different pathways such as altNHEJmightmediate TOP2 induced
rearrangements in the absence of cNHEJ (Gothe et al., 2019).
Further research is required to clarify this point.
Noteworthily, despite in the presence of a sister chromatid
NHEJ still has a dominant role (Beucher et al., 2009; Karanam
et al., 2012), it has been shown that transcriptionally-active
regions are preferentially repaired by HR, promoted by open
chromatin marks (Aymard et al., 2014; Pfister et al., 2014).
This mechanism may moderate mutagenic pathways during
the repair of critical sequences. Why TOP2-induced DSBs
during transcription are so dependent on TDP2 and NHEJ
remains unknown.
THE SYNAPSIS OF TOP2 BREAKS
A major determinant for translocation propensity is the
proximity between donor and acceptor DSBs (Roukos et al.,
2013; Hu et al., 2016). Translocations occur preferentially in
cis and are enhanced within the same topological domain due
to pre-existing spatial proximity (Zhang et al., 2012). Notably,
transcription may not only mediate TOP2 breakage but break
proximity as well. Oncogenic translocation partners are known to
share transcription factories (discrete concentrations of actively
transcribed genes) (Ghamari et al., 2013). That is the case for
IgH andMYC in Burkitt’s lymphoma but also for TOP2 hotspots
such as TMPRSS2 and ERG in prostate and MLL, AF4, and AF9
in bone marrow (Osborne et al., 2007; Lin et al., 2009; Cowell
et al., 2012). Nevertheless, for other pairs such as MLL and ENL,
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an inherent proximity exists, favoring synapsis independently
of transcription (Gothe et al., 2019). The association of TOP2
breaks to loop anchors might also contribute to spatial proximity.
However, a rational comparison of the 3D architecture of the
genome with the genome-wide data of TOP2 abortive breaks is
still missing.
Additionally, in G1, repair in highly transcribed loci is delayed
and breaks dynamically cluster (Aten et al., 2004). The functional
reason for this grouping remains unclear but the absence of a
sister chromatid and the preferential use of HR over NHEJ would
be an explanation (Aymard et al., 2017). However, grouping
unrepaired, and may be partially resected, DSBs seems counter-
productive for genome stability. Favoring TDP2-mediated repair
in TOP2 breaks associated to transcription may be a mechanism
to prevent this situation.
CONCLUSION
High transcription and recurrent DSBs are hallmarks of
oncogenic hotspots. These two factors get together with spatial
proximity and NHEJ-mediated repair in transcription-associated
TOP2 breaks generating the perfect breeding ground for
chromosomal translocations.
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